Esperion Therapeutics (NasdaqGM:ESPR) M&A announcement Transcript

Esperion Therapeutics (NasdaqGM:ESPR) M&A announcement March 03, 2026 08:00 AM ET Company ParticipantsBen Halladay - CFOBetty Jean Swartz - Chief Business OfficerDan Bloomfield - Chief Medical OfficerJohn Harlow - Chief Commercial OfficerSerge Belanger - Managing Director in BioPharma Equity ResearchSheldon Koenig - President and CEOConference Call ParticipantsDavid Amsellem - Managing Director and Senior Research AnalystDennis Ding - Vice President and Equity Research AnalystJoseph Pantginis - Managing Dir ...